Alkosign Board of Directors

Get the latest insights into the leadership at Alkosign. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Samir Narendra Shah Chairman & Managing Director
Mr. Shrenik Kamlesh Shah Whole Time Director
Mr. Akshay Narendra Shah Non Executive Director
Ms. Zeenal Shrenik Shah Non Executive Director
Mr. Parshva Vinaykant Doshi Ind. Non-Executive Director
Mr. Yogesh Ramgopal Gupta Ind. Non-Executive Director
Ms. Seema Ashim Jhaveri Ind. Non-Executive Director

Alkosign Share price

ALKOSIGN

75.4

3.59 (-4.54%)
Last updated on 4 Sep, 2025 | 14:20 IST
BUYSELL
Today's High

75.40

Today's Low

75.40

52 Week Low

46.02

52 Week High

96.71

The current prices are delayed, login to your account for live prices

Alkosign FAQs

The board at Alkosign consists of experienced professionals, including Mr. Samir Narendra Shah , Mr. Shrenik Kamlesh Shah , and others, overseeing the company’s strategic and corporate governance.

Directors at Alkosign are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Samir Narendra Shah is the current chairman at Alkosign.

Executive directors at Alkosign are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Alkosign adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Alkosign, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.